Carlsmed, Inc. (CARL) Narxning foydaga nisbati

Carlsmed, Inc. (CARL) korporativ emblemasi va logotipi

Carlsmed Inc (CARL) shaxsiylashtirilgan jarrohlik implantlarini yaratish orqali daromad keltiradi hamda marjalarni kengaytirish uchun aniq JIT logistikasi va raqamli ishlab chiqarishdan foydalanadi. Ushbu narxlar grafigi modelning samaradorligini tasdiqlaydi, bunda P/E koeffitsiyenti -11.70 darajasida turibdi. Biznes AI tomonidan boshqariladigan 3D umurtqa pog'onasi modellashtirishiga tayanadi, masshtablash esa to'liq avtomatlashtirilgan lazerli kesish va optik tekshirish liniyalarining joriy etilishi bilan amalga oshiriladi.

Carlsmed Medical (CARL) Narx-foyda koeffitsiyenti: 24.07.2025 - 16.11.2026 davri uchun

Carlsmed (CARL) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
Kompaniyaning umumiy tahlili:Carlsmed, Inc. - CARL
carlsmed.com original mahsuloti

Carlsmed Inc (CARL) muvaffaqiyati jarrohlar tomonidan shaxsiylashtirilgan implantlarning qabul qilinishiga va sug'urta to'lovlari shartlariga bog'liq. Kompaniyaning oxirgi o'n ikki oylik (TTM) P/E koeffitsiyenti bozarning ushbu tartibga soluvchi va tijorat risklariga bo'lgan reaksiyasini aks ettiradi. Ushbu koeffitsiyent aktivning bozor qiymatini uning haqiqiy yillik foydasiga nisbatda ko'rsatib, sof foydaning bir dollari uchun to'lanadigan xarajatni o'lchaydi. Bu kelajakdagi o'sishning haddan tashqari qimmat baholanganligi yoki biznesning yetarlicha baholanmaganlik darajasini aniqlash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

Narxning foydaga nisbati BSX|Narx-foyda koeffitsiyenti EW (Edwards Lifesciences Corporation)|Biznesning o‘zini qoplash muddati ResMed Inc.|P/E multiplikatori PODD (insulet.com)|ZBH (Zimmer Biomet Holdings, Inc.) - Kapitalizatsiyaning sof foydaga nisbati|CooperSurgical - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati ALGN|GMED: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati TransMedics Group (TMDX)|ATEC (Alphatec) - P/E multiplikatori|Narx-foyda multiplikatori AORT (Artivion)|Narx-foyda koeffitsiyenti ENOV (Enovis)|IART (Integra LifeSciences Corp) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Establishment Labs Inc ESTA|BBNX - Narx-foyda koeffitsiyenti|IRADIMED Corp - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Embecta Corp.|TNDM: P/E multiplikatori|Narx-foyda multiplikatori AXGN|SIBN (SI-BONE Medical) - P/E multiplikatori|Orthofix International (OFIX) - Biznesning o‘zini qoplash muddati|P/E multiplikatori BVS|Narx-foyda koeffitsiyenti OrthoPediatrics KIDS|P/E multiplikatori TMCI (treace.com)|P/E multiplikatori Blade Air Mobility SRTA|RXST - Narxning foydaga nisbati|CLPT: Narxning foydaga nisbati|STXS (Stereotaxis, Inc.) - Narx-foyda koeffitsiyenti|Neuronetics, Inc. - Kompaniya qiymatining sof foydaga nisbati|SGHT (Sight Sciences Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Orchestra BioMed Inc. OBIO|Narxning foydaga nisbati Anika Therapeutics, Inc. (ANIK)|InspireMD, Inc. (NSPR) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Jin Medical International Ltd. - Narx-foyda koeffitsiyenti|P/E multiplikatori Vivani VANI|Xtant Medical Holdings, Inc. - P/E multiplikatori|Biznesning o‘zini qoplash muddati NeuroOne NMTC|Modular Medical, Inc. (MODD) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Myomo, Inc|Narxning foydaga nisbati envoymedical.com|Narx-foyda koeffitsiyenti Vivos Therapeutics (VVOS)|P/E multiplikatori NVNO|SINT - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Tenon Medical, Inc. TNON|LFWD: Narx-foyda multiplikatori|AMIX: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati invobioscience.com IVF|BBLG: P/E multiplikatori|Axonics Modulation Technologies (AXNX) - P/E multiplikatori|BIOL (Biolase Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati dynatronics.com DYNT|P/E multiplikatori FNA|Narxning foydaga nisbati INVO (INVO Bioscience Inc.)